Neurodevelopmental disorders encompass conditions like autism spectrum disorders and attention-deficit/hyperactivity disorder. These conditions, often diagnosed in childhood, require a nuanced understanding for effective management. The Journal of Clinical Psychiatry offers comprehensive insights into neurodevelopmental disorders, emphasizing their psychiatric implications and evidence-based therapeutic strategies. Our expert editors curate content that is both clinically relevant and actionable, ensuring psychiatrists are well-equipped to provide holistic care.
Neurodevelopmental Disorders
Page 3
Recently published articles about Neurodevelopmental
Original Research
Efficacy and Safety of AR19 in Adults With ADHD
August 24, 2021
Misuse of stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) can have adverse medical outcomes. This study tested the safety and efficacy of AR19, a manipulation-resistant formulation of amphetamine, in...
Insights
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
August 24, 2021
AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the...
Original Research
Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD
June 29, 2021
Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
Original Research
Response and Remission with DR/ER-MPH
June 22, 2021
Delayed-release and extended-release methylphenidate (DR/ER-MPH) has shown marked improvement in ADHD symptoms and functional impairment. This post hoc analysis examined response and remission thresholds for DR/ER-MPH in the context...
Original Research
Relationships Between Executive Function and ADHD Symptom Improvement With Lisdexamfetamine
May 28, 2020
This study used post hoc path analyses to examine reciprocal relationships between improvement in executive function and ADHD symptoms from a double-blind, placebo-controlled study of lisdexamfetamine in adults with...
Original Research
Guanfacine Extended-Release Improves ADHD Symptoms in Japanese Adults
April 14, 2020
Existing treatments for attention-deficit/hyperactivity disorder (ADHD) in adults, though effective, have limitations. This study examined the efficacy and safety of guanfacine extended-release in adults with ADHD.
